|
Originally published In Press as doi:10.1074/jbc.R000029200 on October 20, 2000
J. Biol. Chem., Vol. 275, Issue 50, 38949-38952, December 15, 2000
MINIREVIEW
The Zinc Finger-containing Transcription Factors GATA-4, -5, and -6
UBIQUITOUSLY EXPRESSED REGULATORS OF TISSUE-SPECIFIC GENE
EXPRESSION*
Jeffery D.
Molkentin
From the Department of Pediatrics, University of Cincinnati,
Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039
 |
INTRODUCTION |
Six GATA transcription factors have been
identified in vertebrates, each of which contains a highly conserved
DNA binding domain consisting of two zinc fingers of the motif
Cys-X2-Cys-X17-Cys-X2-Cys (1-9) that directs binding to the nucleotide sequence element (A/T)GATA(A/G) (10, 11). Based on their expression patterns, the GATA
proteins have been divided into two subfamilies, GATA-1, -2, and -3 and
GATA-4, -5, and -6. GATA-1, -2, and -3 genes are prominently expressed in hematopoietic stem cells where they regulate differentiation-specific gene expression in T-lymphocytes, erythroid cells, and megakaryocytes (reviewed in Ref. 12). GATA-4, -5, and -6 genes are expressed in various mesoderm- and
endoderm-derived tissues such as heart, liver, lung, gonad, and gut
where they play critical roles in regulating tissue-specific gene
expression (4-9). Consistent with the observed expression patterns for
GATA-4, -5, and -6, targeted disruption of each gene in the mouse has revealed important functions in heart, endoderm, lung epithelium, and
genitourinary tract formation. Here we will discuss the biochemical characteristics and transcriptional regulatory roles of GATA-4, -5, and
-6 transcription factors.
 |
Structure-Function Analysis of GATA-4, -5, and -6 Proteins |
The mouse GATA-4, -5, and -6 genes encode
proteins of 48, 42, and 45 kDa, respectively (4, 7, 8). Each protein
contains a highly conserved DNA binding domain that consists of two
zinc finger motifs and two adjacent stretches of basic amino acids (Fig. 1, A and B).
GATA-4, -5, and -6 are ~85% identical to one another at the amino acid level within the DNA binding region containing the zinc finger and basic regions (Fig. 1B).
Furthermore, mouse GATA-4 is ~70% identical to mouse
GATA-1 and Drosophila pannier within the DNA
binding region, suggesting a high degree of sequence conservation
between divergent GATA family members and across evolutionary disparate
organisms (Fig. 1A).

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 1.
Structural domains and amino acid sequences
of GATA-4, -5, and -6 transcription factors. A, GATA-4
contains two distinct zinc finger domains (Zn) and a
C-terminal nuclear localization sequence (nls) that together
constitute the DNA binding and protein-protein interaction domain.
GATA-4 also contains two transcriptional activation domains
(TAD) in the N terminus. B, amino acid sequence
of the two zinc finger domains and the adjacent basic regions. Mouse
GATA-1 and D. pannier amino acid sequences are also shown
for comparison. The blue shaded region
represents identity to GATA-4 (consensus) whereas unshaded
areas represent differences in amino acid sequence. The
asterisk shows the cysteines that generate each zinc finger
subdomain, whereas the arrow denotes the position of a
3-amino acid insertion (sequence not shown) that is uniquely present in
pannier.
|
|
Given the high degree of sequence identity between GATA protein family
members, predictions can be drawn as to the residues that mediate DNA
binding in GATA-4, -5, and -6 based on structural and mutagenesis
studies performed in GATA-1. A number of reports have demonstrated that
only the C-terminal zinc finger and adjacent basic domain are necessary
for specific DNA binding in vitro (13-15). Using NMR,
GATA-1 was shown to interact with 8 nucleotide base pairs when bound to
DNA such that the N-terminal and central portion of the GATA-1 DNA
binding domain made specific contacts within the major groove, whereas
the C-terminal portion made site-specific interactions within the minor
groove (13). Whereas just the C-terminal finger of GATA-1 is required
for specific DNA binding, the N-terminal finger can interact with
adjacent GATA DNA sequence elements or with protein cofactors (16, 17).
Protein domain deletion analysis of GATA-4 confirms that the C-terminal
zinc finger is necessary and sufficient for DNA binding, as with GATA-1 (18).
The nuclear localization and transcriptional activation domains of
GATA-4 have also been identified (18). Deletion analysis suggests that
a strong nuclear localization sequence is present within the basic
domain adjacent to the C-terminal finger (amino acids 251-324),
whereas two separate transcriptional activation domains are present
within the N terminus of the protein (18) (Fig. 1A).
Interestingly these transcriptional activation domains are partially
conserved in GATA-5 and -6, suggesting a similar mechanism of
transcriptional activation within the GATA-4, -5, and -6 subfamily
(18). However, a naturally occurring splice variant of GATA-5 lacking
the N-terminal activation domain still promotes modest transcriptional
activation suggesting the presence of a weak transcriptional activation
domain in the C terminus of GATA-5 (19).
Using polymerase chain reaction site selection, GATA-1, -2, and -3 were
each determined to bind the DNA consensus site (A/T)GATA(A/G), whereas
GATA-2 and GATA-3 were also capable of binding the GATA-like site
AGATCTT (10, 11). Characterization of the 5'-regulatory regions of
numerous genes has demonstrated that GATA-4, -5, and -6 factors also
interact with a DNA sequence element containing a core GATA motif. More
recently, polymerase chain reaction site selection with GATA-6 protein
demonstrated an order of site preference to be GATA>GATT>GATC (20).
These analyses suggest that although GATA factors universally recognize
a GATA DNA sequence element, subtle differences in the GATA core DNA
motif might promote differential binding among coexpressed GATA family
members within a specific tissue. Indeed, GATA-4, but not GATA-2 or
GATA-3, specifically regulates expression of the interleukin-5
gene in a human T-cell line (21). In addition, activation of the -
and -myosin heavy chain promoters preferentially utilized GATA-4
over GATA-6 in cardiac myocytes (22). Finally, the promoter of the
novel phosphoprotein gene Dab2 was regulated by GATA-6, but
not GATA-4, in visceral endoderm (23). Collectively, these studies
indicate that although GATA-4, -5, and -6 each bind a GATA or GATA-like
sequence element, their individual affinities for various promoters
might depend on flanking nucleotide sequences or even on interactions
with cofactors and other transcription factors. Such interactions might also provide a complex transcriptional code that allows programming of
tissue-specific gene expression, despite a relatively broad expression
pattern in multiple mesodermal and endodermal derived tissues.
 |
Expression Patterns and Gene Targeting in the Mouse |
In the adult mouse, GATA-4 mRNA is detected in the heart,
ovary, testis, lung, liver, and small intestine (4). In embryonic and
fetal mice, GATA-4 is expressed in the heart, proximal and distal gut, testis, ovary, liver, visceral endoderm, and parietal endoderm (4, 7). GATA-5 gene is expressed in the adult small intestine, stomach, bladder, and lungs whereas developmentally expression is detected in the allantois, heart, outflow tract, lung
bud, urogenital ridge, bladder, and gut epithelium (8). Finally, mouse
GATA-6 is expressed in the adult heart, aorta, stomach,
small intestine, and bladder and weakly in the liver and lung (7).
During embryonic and fetal development, GATA-6 mRNA is detected in
the primitive streak, allantois, visceral endoderm, heart, lung buds,
urogenital ridge, vascular smooth muscle cells, and the epithelial
layer of the stomach, small intestine, and large intestine (7, 9, 24,
25). Collectively, these studies indicate that most tissues of either
mesodermal or endodermal origin express one or more GATA-4, -5, or -6 factors at some point during development. Given these characteristic
broad fields of expression one might predict that GATA-4, -5, and -6 factors are unlikely to act as master regulators of cell type
specificity or determination. For example, the MyoD family of basic
helix-loop-helix transcription factors is exclusively expressed in
skeletal muscle, where they act as master regulators of myoblast cell
identity and differentiation. However, it remains possible that GATA-4, -5, and -6 might still serve a function in regulating cell type specification or determination through unique interactions with other
semi-restricted transcription factors. Such a notion is also consistent
with the observed role of GATA-1, -2, and -3 as master regulators of
erythroid and lymphoid cell identity, despite the observation that each
factor is expressed outside hematopoietic cell lineages (12).
Targeted disruption of the GATA-4, -5, and -6 genes in the mouse has revealed phenotypes consistent with their
individual expression patterns. Mice null for GATA-4 die
between embryonic day 8 and 9 because of defects in heart morphogenesis
and ventral closure of the foregut (26, 27). Specifically,
GATA-4 null mice present with cardia bifida because of
ineffective ventral fusion of the lateral aspects of the embryo and the
subsequent formation of the foregut. Aberrant heart formation in
GATA-4 null mice is likely a secondary effect associated
with an intrinsic defect in the definitive endoderm that underlies the
splanchnic mesoderm containing the cardiac field (28). This
interpretation is further supported by the observation that
GATA-4 null embryonic stem cells can generate cardiac
myocytes but are partially defective in their ability to generate
visceral endoderm and definitive endoderm of the foregut (27, 29, 30).
Finally, a role for GATA-4 in heart development is further suggested by
the identification of a deletion in human chromosome 8p23.1 that
contains the GATA-4 gene and is associated with congenital
heart disease (31, 32). Taken together, it is likely that GATA-4
regulates cardiac development by both direct and indirect mechanisms.
Targeted disruption of the GATA-5 gene in the mouse did not
result in developmental lethality but instead females displayed defects
in genitourinary tract development (33), consistent with the observed
pattern of GATA-5 expression in the urogenital ridge during
embryogenesis (8). Interestingly, a GATA-5 null mutation in
zebrafish resulted in embryonic lethality with an identical phenotype
to that observed in GATA-4 null mice, suggesting a reversal
in the roles of GATA-4 and GATA-5 between the
mouse and fish (34). GATA-6 null mice die during early
embryonic development (embryonic day 5.5-7.5) because of defects in
visceral endoderm function and subsequent extraembryonic development
(35, 36), a phenotype that is consistent with the expression pattern of GATA-6 in the embryonic primitive endoderm (7). In the
future, it will be interesting to generate tissue-specific disruptions of GATA-4 and -6 in the mouse using cre-lox technology to permit a more careful evaluation of the role that each factor plays in regulating of tissue-specific gene expression in the heart, gut, lung,
and liver.
Expression of GATA-4 and -6 is dependent on one
another given the observation that GATA-6 is up-regulated in
GATA-4 null mice and that GATA-6 null embryos
show down-regulation of GATA-4 (26, 27, 36). Although the
mechanism underlying this regulation has not been elucidated, it is
tempting to speculate that GATA-4 negatively regulates GATA-6 gene
expression whereas GATA-6 positively regulates GATA-4 gene expression.
Such a transcriptional interconnection between GATA-4 and GATA-6 is
also consistent with the observations that GATA-4 and
-6 double heterozygous mice are nonviable and die during
embryonic development.1
Alternatively, it is also possible that the absolute dosage of GATA-4
and -6 proteins is critical for proper development. An interdependence between these two transcription factors is also supported by the observation that GATA-4 and -6 proteins colocalize with one another in the nucleus of cardiac myocytes and form stable dimeric complexes (22).
 |
Role of GATA-4, -5, and -6 in Tissue-specific Gene
Expression |
GATA-4, -5, and -6 have been implicated as important regulators of
gene expression in heart, liver, gonad, gut epithelium, and lung.
GATA-4 regulates expression of a number of cardiac structural genes
such as -myosin heavy chain, cardiac troponin-C, atrial natriuretic factor and brain natriuretic peptide, cardiac
troponin-I, sodium/calcium exchanger,
cardiac restricted ankyrin repeat protein, A1 adenosine
receptor, m2 muscarinic receptor, and the myosin light chain
1/3 (37-49). GATA factors also regulate developmental expression of
the cardiac transcription factor Nkx2.5, suggesting the existence of a
reinforcing transcriptional regulatory circuit between Nkx2.5 and GATA
factors in the heart (50, 51).
Furthermore, the Drosophila
GATA factor, pannier, regulates expression of the myocyte
enhancer factor-2 (MEF-2)2 gene in cardioblasts,
extending the role of GATA factors as regulators of heart gene
expression to include invertebrates (52). Collectively, the studies
discussed above indicate that GATA factors are important regulators of
both structural and regulatory genes in the heart.
GATA-6 has been implicated in the transcriptional regulation of genes
within the respiratory epithelium of the lung. Specifically, GATA-6
regulates expression of the surfactant protein A and thyroid transcription factor-1 (TTF-1) promoters (53, 54). Interestingly, GATA-5 was unable to regulate TTF-1 promoter activity, suggesting a
specific role for GATA-6 in the lung (54). That GATA-6 is an important
lung-determining factor is further supported by the observation that
GATA-6 null embryonic stem cells fail to contribute to the
lung epithelium in chimeric mouse embryos (36).
GATA-4, -5, and -6 have also been implicated in the regulation of
epithelial cell differentiation in the gut, where they regulate expression of the H+/K+-ATPase and the trefoil
factor family promoters (55-58). GATA proteins are also required for
efficient gene expression in the gut of Caenorhabditis
elegans, suggesting an evolutionary conserved role for GATA
factors in gut development between vertebrates and invertebrates (59).
GATA-4 and -6 have also been implicated in the regulation of
liver-specific gene expression through analysis of the albumin promoter, vitellogenin II promoter, and the liver-enriched homeobox gene promoter, Hex (60-62). GATA-4, -5, and -6 factors are also important regulators of gene expression within the gonads. Expression of the Mullerian inhibiting substance promoter is regulated by GATA-4
in Sertoli cells and Mullerian ducts (63-65), and GATA-4 regulates
expression of the steroidogenic acute regulatory protein promoter in the ovary (66). Collectively, these various studies indicate that GATA-4, -5, and -6 factors are important regulators of
tissue-specific gene expression in multiple endoderm- and
mesoderm-derived tissues. However, it is likely that GATA-4, -5, and -6 factors regulate tissue-specific gene expression across these divergent cell types through specific interactions with other semi-restricted transcription factors or cofactors (see below).
 |
GATA-4, -5, and -6 Regulate Inducible Gene Expression |
GATA-4 has been implicated as a regulator of inducible gene
expression in cardiac myocytes in response to hypertrophic stimulation. Specifically, analysis of the -myosin heavy chain promoter in aortic-banded rats (pressure overload) revealed a proximal GATA binding site that directed hypertrophy-responsive gene expression (67).
In a similar approach, GATA-4 was implicated as a regulator of
angiotensin type-1A receptor promoter in response to pressure overload
stimulation in the adult rat heart (68). In cultured neonatal
cardiomyocytes, electrical pacing-induced hypertrophy was associated
with a significant increase in GATA-4 mRNA, suggesting a mechanism
of regulation whereby total GATA-4 content is up-regulated during
hypertrophy (69). Alternatively, GATA-4 transcriptional activity might
also be regulated by phosphorylation mediated by extracellular
signal-regulated kinase in response to hypertrophic agonist
administration (70). Finally, GATA-5 was shown to mediate leukemia
inhibitory factor-induced expression of the -myosin heavy
chain promoter in cultured cardiomyocytes (71). Collectively, these
various reports implicate GATA transcription factors as important
regulators of hypertrophy-associated gene expression in cardiomyocytes.
Evidence suggests that both transcriptional and post-transcriptional
mechanisms are involved in augmenting GATA-4 potency during hypertrophy
in cardiac myocytes.
Analysis of vascular smooth muscle cells has demonstrated an important
role for GATA-6 in regulating cell proliferation in response to
mitogenic or mechanical stimulation. GATA-6 mRNA levels are
down-regulated in proliferating vascular smooth muscle cells, suggesting that GATA-6 expression is linked to the cell cycle in these
cells (9). More specifically, forced expression of GATA-6 in vascular
smooth muscle cells induced growth arrest through a mechanism involving
enhanced expression of the cyclin-dependent kinase
inhibitor p21 (72). In vivo, adenovirus-mediated gene transfer of GATA-6 in balloon-injured carotid arteries prevented vessel
lesions associated with vascular smooth muscle cell phenotypic modulation (73). These studies suggest that GATA-6 is an important regulator of vascular smooth muscle cell proliferation and subsequent vascular injury. It will be of interest to determine whether GATA-6 controls cell cycle arrest in other cell types in which it is expressed
or if such regulation is unique to vascular smooth muscle cells.
 |
GATA-4, -5, and -6 Interacting Factors |
A vast array of GATA-4, -5, and -6 interacting proteins has been
described, including both DNA binding factors and general transcriptional activators and repressors. It is likely that such a
wide array of interacting factors reflects transcriptional mechanisms whereby tissue-specific gene expression is orchestrated across various
mesodermal and endodermal cell types. In the heart, GATA-4 directly
interacts with the transcription factor Nkx2.5 to regulate expression
of the atrial natriuretic factor and cardiac -actin promoter
(74-76). This interaction is mediated by the C-terminal zinc finger
domain of GATA-4 and helix III of the homeodomain of Nkx2.5 (74-76).
GATA-4 also physically interacts by way of the C-terminal zinc finger
with nuclear factor of activated T-cells-c4 (NFATc4) and MEF-2 in the
regulation of cardiac gene expression (77, 78). Such results suggest a
paradigm whereby GATA-4 regulates heart-specific gene expression
through complexes with other heart-expressed transcription
factors. In Sertoli cells, GATA-4 was shown to physically interact with
the nuclear receptor, SF-1, leading to transcriptional synergy on the
Mullerian inhibiting substance gene promoter (63). Finally, GATA-4 and
-6 were shown to physically interact with one another in cardiac
myocytes suggesting heterodimerization between GATA factors (22).
It is uncertain how the C-terminal zinc finger domain of GATA-4 is
capable of mediating interactions with such a broad array of disparate
transcription factors, especially because this same protein domain
makes direct nucleotide contacts within the major groove of DNA.
Despite this concern, it is formally possible that GATA-4 directly
interacts with each of the characterized transcription factors as part
of a cell type-specific complex (Fig.
2A). However, it is also
possible that GATA-4 exists as a heterogenous pool consisting of only
one or a few of these cofactors at any one time. Alternatively, GATA-4
may exist as a large complex with other transcription factors through
an indirect association with general regulators of transcription such
as p300/CBP (Fig. 2B). Consistent with this
hypothesis, GATA-5 and -6 were each shown to physically interact with
p300 resulting in transcriptional synergy (79, 80), and CBP was
reported to stimulate transcription dependent on GATA-4 (81). More
recently, GATA-4 was shown to interact with the transcriptional
modifying protein, friend of GATA-2 (FOG-2), through a physical
interaction involving the N-terminal zinc finger of GATA-4 (82-84).
This interaction is conserved in Drosophila where the FOG-2
homologue, U-shaped, interacts with pannier, a GATA homologue (85). It is likely that FOG-2
plays an important role in regulating GATA factor-dependent
gene expression in the heart given the phenotype of FOG-2 knock-out
mice that die during embryogenesis with significant cardiac
abnormalities (86, 87). It is uncertain if FOG-2 acts as a general
transcriptional activator or repressor of GATA-4, -5, and -6 factors or
if transcriptional modifying activity varies from cell type to cell
type. However, FOG-2 also interacts with the transcriptional repressor
protein, CtBP2, implicating FOG-2 as a general transcriptional
repressor of GATA-4, -5, and -6 activity (88).

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 2.
Two models of GATA-4 transcriptional
complexes that could regulate cardiac gene expression.
A, the C-terminal zinc finger domain of GATA-4 may directly
interact with the transcription factors Nkx2.5, NFATc4, and MEF2 as
well as CBP, whereas FOG-2 interacts with the N-terminal zinc finger.
It is uncertain if GATA-4 can interact with each of these factors at
the same time or if interaction with one precludes further
interactions. B, alternatively, GATA-4 may indirectly
interact with Nkx2.5, NFATc4, and MEF2 through a mutual association
with CBP (or p300).
|
|
 |
Model of GATA-4, -5, and -6 as Tissue-unrestricted Enhancer
Factors |
Whereas the majority of studies pertaining to GATA-4, -5, and -6 transcription factors have focused on cardiac expressed genes, recent
evidence indicates that multiple tissues utilize GATA-4, -5, or -6 factors in programming cell type-specific gene expression. However, it
is uncertain how a family of widely expressed transcription factors
might regulate differentiation-specific gene expression and tissue
identity in such diverse cell types as heart, lung, and liver. Tissue
specificity afforded by GATA-4, -5, or -6 transcription factors may
arise through cell type-specific interactions with other transcription
factors that themselves are expressed in semi-restricted patterns. For
example, GATA-4 physically interacts with the transcription factors
Nkx2.5, MEF-2, and NFATc4, which together are coexpressed uniquely in
the myocardium. In the lung, GATA-6 physically interacts with the
semi-restricted homeobox factor TTF-1, suggesting a unique combinatorial transcriptional code that is specific to the lung. In
conclusion, numerous studies have established a paradigm whereby the
subfamily of GATA-4, -5, and -6 factors regulates tissue-specific gene
expression in multiple cell types through unique interactions with
other semi-restricted transcription factors.
 |
ACKNOWLEDGEMENTS |
I thank Dr. Katherine Yutzey for critical
evaluation of this manuscript. I apologize for omitting many relevant
studies because of space constraints.
 |
FOOTNOTES |
*
This minireview will be reprinted
in the 2000 Minireview Compendium, which
will be available in December, 2000.
To whom correspondence should be addressed: Division of Molecular
Cardiovascular Biology, Department of Pediatrics, Children's Hospital
Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039. E-mail:
molkj0@chmcc.org.
Published, JBC Papers in Press, October 20, 2000, DOI 10.1074/jbc.R000029200
1
J. D. Molkentin and E. N. Olson, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
MEF-2, myocyte
enhancer factor-2;
TTF-1, thyroid transcription factor-1;
NFATc4, nuclear factor of activated T-cells-c4;
FOG-2, friend of GATA-2;
CBP, CREB-binding protein.
 |
REFERENCES |
| 1.
|
Evans, T.,
and Felsenfeld, G.
(1989)
Cell
58,
877-885
|
| 2.
|
Tsai, S.-F.,
Martin, D. I.,
Zon, L. I.,
D'Andrea, A. D.,
Wong, G. G.,
and Orkin, S. H.
(1989)
Nature
339,
446-451
|
| 3.
|
Yamamoto, M.,
Ko, L. J.,
Leonard, M. W.,
Beug, H.,
Orkin, S. H.,
and Engel, J. D.
(1990)
Genes Dev.
4,
1650-1662
|
| 4.
|
Arceci, R. J.,
King, A. A. J.,
Simon, M. C.,
Orkin, S. H.,
and Wilson, D. B.
(1993)
Mol. Cell. Biol.
13,
2235-2246
|
| 5.
|
Kelley, C.,
Blumberg, H.,
Zon, L. I.,
and Evans, T.
(1993)
Development
118,
817-827
|
| 6.
|
Laverriere, A. C.,
MacNeill, C.,
Mueller, C.,
Poelmann, R. E.,
Burch, J. B. E.,
and Evans, T.
(1994)
J. Biol. Chem.
269,
23177-23184
|
| 7.
|
Morrisey, E. E.,
Ip, H. S.,
Lu, M. M.,
and Parmacek, M. S.
(1996)
Dev. Biol.
177,
309-322
|
| 8.
|
Morrisey, E. E.,
Ip, H. S.,
Tang, Z.,
Lu, M. M.,
and Parmacek, M. S.
(1997)
Dev. Biol.
183,
21-36
|
| 9.
|
Suzuki, E.,
Evans, T.,
Lowry, J.,
Truong, L.,
Bell, D. W.,
Testa, J. R.,
and Walsh, K.
(1996)
Genomics
38,
283-290
|
| 10.
|
Ko, J. L.,
and Engel, J. D.
(1993)
Mol. Cell. Biol.
13,
4011-4022
|
| 11.
|
Merika, M.,
and Orkin, S. H.
(1993)
Mol. Cell. Biol.
13,
3999-4010
|
| 12.
|
Orkin, S. H.
(1998)
Int. J. Dev. Biol.
42,
927-934
|
| 13.
|
Omichinski, J. G.,
Trainor, C.,
Evans, T.,
Gronenborn, A. M.,
Clore, G. M.,
and Felsenfeld, G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1676-1680
|
| 14.
|
Visvader, J. E.,
Crossley, M.,
Hill, J.,
Orkin, S. H.,
and Adams, J. M.
(1995)
Mol. Cell. Biol.
15,
634-641
|
| 15.
|
Yang, H-Y.,
and Evans, T.
(1992)
Mol. Cell. Biol.
12,
4562-4570
|
| 16.
|
Weiss, M. J., Yu, C.,
and Orkin, S. H.
(1997)
Mol. Cell. Biol.
17,
1642-1651
|
| 17.
|
Trainor, C. D.,
Omichinski, J. G.,
Vandergon, T. L.,
Gronenborn, A. M.,
Clore, G. M.,
and Felsenfeld, G.
(1996)
Mol. Cell. Biol.
16,
2238-2247
|
| 18.
|
Morrisey, E. E.,
Ip, H. S.,
Tang, Z.,
and Parmacek, M. S.
(1997)
J. Biol. Chem.
272,
8515-8524
|
| 19.
|
MacNeill, C.,
Ayres, B.,
Laverriere, A. C.,
and Burch, J. B.
(1997)
J. Biol. Chem.
272,
8396-8401
|
| 20.
|
Sakai, Y.,
Nakagawa, R.,
Sato, R.,
and Maeda, M.
(1998)
Biochem. Biophys. Res. Commun.
250,
682-688
|
| 21.
|
Yamagata, T.,
Nishida, J.,
Sakai, R.,
Tanaka, T.,
Honda, H.,
Hirano, N.,
Mano, H.,
Yazaki, Y.,
and Hirai, H.
(1995)
Mol. Cell. Biol.
15,
3830-3839
|
| 22.
|
Charron, F.,
Paradis, P.,
Bronchain, O.,
Nemer, G.,
and Nemer, M.
(1999)
Mol. Cell. Biol.
19,
4355-4365
|
| 23.
|
Morrisey, E. E.,
Musco, S.,
Chen, M. Y.,
Lu, M. M.,
Leiden, J. M.,
and Parmacek, M. S.
(2000)
J. Biol. Chem.
275,
19949-19954
|
| 24.
|
Narita, N.,
Heikinheimo, M.,
Bielinska, M.,
White, R. A.,
and Wilson, D. B.
(1996)
Genomics
36,
345-348
|
| 25.
|
Huggon, I. C.,
Davies, A.,
Gove, C.,
Moscoso, G.,
Moniz, C.,
Foss, Y.,
Farzaneh, F.,
and Towner, P.
(1997)
Biochim. Biophys. Acta
1353,
98-102
|
| 26.
|
Molkentin, J. D.,
Lin, Q.,
Duncan, S. A.,
and Olson, E. N.
(1997)
Genes Dev.
11,
1061-1072
|
| 27.
|
Kuo, C. T.,
Morrisey, E. E.,
Anandappa, R.,
Sigrist, K.,
Lu, M. M.,
Parmacek, M. S.,
Soudais, C.,
and Leiden, J. M.
(1997)
Genes Dev.
11,
1048-1060
|
| 28.
|
Narita, N.,
Bielinska, M.,
and Wilson, D. B.
(1997)
Dev. Biol.
189,
270-274
|
| 29.
|
Narita, N.,
Bielinska, M.,
and Wilson, D. B.
(1997)
Development
124,
3755-3764
|
| 30.
|
Soudais, C.,
Bielinska, M.,
Heikinheimo, M.,
MacArthur, C. A.,
Narita, N.,
Saffitz, J. E.,
Simon, M. C.,
Leiden, J. M.,
and Wilson, D. B.
(1995)
Development
121,
3877-3888
|
| 31.
|
Pehlivan, T.,
Pober, B. R.,
Brueckner, M.,
Garrett, S.,
Slaugh, R.,
Van Rheeden, R.,
Wilson, D. B.,
Watson, M. S.,
and Hing, A. V.
(1999)
Am. J. Med. Genet.
83,
201-206
|
| 32.
|
Bhatia, S. N.,
Suri, V.,
Bundy, A.,
and Krauss, C. M.
(1999)
Prenat. Diagn.
19,
863-867
|
| 33.
|
Molkentin, J. D.,
Tymitz, K. M.,
Richardson, J. A.,
and Olson, E. N.
(2000)
Mol. Cell. Biol.
20,
5256-5260
|
| 34.
|
Reiter, J. F.,
Alexander, J.,
Rodaway, A.,
Yelon, D.,
Patient, R.,
Holder, N.,
and Stainier, D. Y.
(1999)
Genes Dev.
13,
2983-2995
|
| 35.
|
Koutsourakis, M.,
Langeveld, A.,
Patient, R.,
Beddington, R.,
and Grosveld, F.
(1999)
Development
126,
723-732
|
| 36.
|
Morrisey, E. E.,
Tang, Z.,
Sigrist, K.,
Lu, M. M.,
Jiang, F.,
Ip, H. S.,
and Parmacek, M. S.
(1998)
Genes Dev.
12,
3579-3590
|
| 37.
|
Thuerauf, D. J.,
Hanford, D. S.,
and Glembotski, C. C.
(1994)
J. Biol. Chem.
269,
17772-17775
|
| 38.
|
Molkentin, J. D.,
Kalvakolanu, D. V.,
and Markham, B. E.
(1994)
Mol. Cell. Biol.
14,
4947-4957
|
| 39.
|
Grepin, C.,
Dagnino, L.,
Robitaille, L.,
Haberstroh, L.,
Antakly, T.,
and Nemer, M.
(1994)
Mol. Cell. Biol.
14,
3115-3129
|
| 40.
|
Ip, H. S.,
Wilson, D. B.,
Heikinheimo, M.,
Tang, Z.,
Ting, C. N.,
Simon, M. C.,
Leiden, J. M.,
and Parmacek, M. S.
(1994)
Mol. Cell. Biol.
14,
7517-7526
|
| 41.
|
McGrew, M. J.,
Bogdanova, N.,
Hasegawa, K.,
Hughes, S. H.,
Kitsis, R. N.,
and Rosenthal, N.
(1996)
Mol. Cell. Biol.
16,
4524-4534
|
| 42.
|
Murphy, A. M.,
Thompson, W. R.,
Peng, L. F.,
and Jones, L., II
(1997)
Biochem. J.
322,
393-401
|
| 43.
|
Di Lisi, R.,
Millino, C.,
Calabria, E.,
Altruda, F.,
Schiaffino, S.,
and Ausoni, S.
(1998)
J. Biol. Chem.
273,
25371-25380
|
| 44.
|
Bhavsar, P. K.,
Dellow, K. A.,
Yacoub, M. H.,
Brand, N. J.,
and Barton, P. J.
(2000)
J. Mol. Cell. Cardiol.
32,
95-108
|
| 45.
|
Nicholas, S. B.,
and Philipson, K. D.
(1999)
Am. J. Physiol.
277,
H324-H330
|
| 46.
|
Cheng, G.,
Hagen, T. P.,
Dawson, M. L.,
Barnes, K. V.,
and Menick, D. R.
(1999)
J. Biol. Chem.
274,
12819-12826
|
| 47.
|
Rivkees, S. A.,
Chen, M.,
Kulkarni, J.,
Browne, J.,
and Zhao, Z.
(1999)
J. Biol. Chem.
274,
14204-14209
|
| 48.
|
Rosoff, M. L.,
and Nathanson, N. M.
(1998)
J. Biol. Chem.
273,
9124-9129
|
| 49.
|
Kuo, H.,
Chen, J.,
Ruiz-Lozano, P.,
Zou, Y.,
Nemer, M.,
and Chien, K. R.
(1999)
Development
126,
4223-4234
|
| 50.
|
Lien, C. L.,
Wu, C.,
Mercer, B.,
Webb, R.,
Richardson, J. A.,
and Olson, E. N.
(1999)
Development
126,
75-84
|
| 51.
|
Searcy, R. D.,
Vincent, E. B.,
Liberatore, C. M.,
and Yutzey, K. E.
(1998)
Development
125,
4461-4470
|
| 52.
|
Gajewski, K.,
Fossett, N.,
Molkentin, J. D.,
and Schulz, R. A.
(1998)
Development
126,
5679-5688
|
| 53.
|
Bruno, M. D.,
Korfhagen, T. R.,
Liu, C.,
Morrisey, E. E.,
and Whitsett, J. A.
(2000)
J. Biol. Chem.
275,
1043-1049
|
| 54.
|
Shaw-White, J. R.,
Bruno, M. D.,
and Whitsett, J. A.
(1999)
J. Biol. Chem.
274,
2658-2664
|
| 55.
|
Gao, X.,
Sedgwick, T.,
Shi, Y. B.,
and Evans, T.
(1998)
Mol. Cell. Biol.
18,
2901-2911
|
| 56.
|
Tamura, S.,
Wang, X. H.,
Maeda, M.,
and Futai, M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10876-10880
|
| 57.
|
Nishi, T.,
Kubo, K.,
Hasebe, M.,
Maeda, M.,
and Futai, M.
(1997)
J. Biochem. (Tokyo)
121,
922-929
|
| 58.
|
Al-azzeh, E. D.,
Fegert, P.,
Blin, N.,
and Gott, P.
(2000)
Biochim. Biophys. Acta
1490,
324-332
|
| 59.
|
Britton, C.,
McKerrow, J. H.,
and Johnstone, I. L.
(1998)
J. Mol. Biol.
283,
15-27
|
| 60.
|
Bossard, P.,
and Zaret, K. S.
(1998)
Development
125,
4909-4017
|
| 61.
|
Davis, D. L.,
and Burch, J. B.
(1996)
Mol. Endocrinol.
10,
937-944
|
| 62.
|
Denson, L. A.,
McClure, M. H.,
Bogue, C. W.,
Karpen, S. J.,
and Jacobs, H. C.
(2000)
Gene (Amst.)
246,
311-320
|
| 63.
|
Tremblay, J. J.,
and Viger, R. S.
(1999)
Mol. Endocrinol.
13,
1388-1401
|
| 64.
|
Viger, R. S.,
Mertineit, C.,
Trasler, J. M.,
and Nemer, M.
(1998)
Development
125,
2665-2675
|
| 65.
|
Watanabe, K.,
Clarke, T. R.,
Lane, A. H.,
Wang, X.,
and Donahoe, P. K.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1624-1629
|
| 66.
|
Silverman, E.,
Eimerl, S.,
and Orly, J.
(1999)
J. Biol. Chem.
274,
17987-17996
|
| 67.
|
Hasegawa, K.,
Lee, S. J.,
Jobe, S. M.,
Markham, B. E.,
and Kitsis, R. N.
(1997)
Circulation
96,
3943-3953
|
| 68.
|
Herzig, T. C.,
Jobe, S. M.,
Aoki, H.,
Molkentin, J. D.,
Cowley, A. W., Jr.,
Izumo, S.,
and Markham, B. E.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7543-7548
|
| 69.
|
Xia, Y.,
McMillin, J. B.,
Lewis, A.,
Moore, M.,
Zhu, W. G.,
Williams, R. S.,
and Kellems, R. E.
(2000)
J. Biol. Chem.
275,
1855-1863
|
| 70.
|
Morimoto, T.,
Hasegawa, K.,
Kaburagi, S.,
Kakita, T.,
Wada, H.,
Yanazume, T.,
and Sasayama, S.
(2000)
J. Biol. Chem.
275,
13721-13726
|
| 71.
|
Morimoto, T.,
Hasegawa, K.,
Kaburagi, S.,
Kakita, T.,
Masutani, H.,
Kitsis, R. N.,
Matsumori, A.,
and Sasayama, S.
(1999)
J. Biol. Chem.
274,
12811-12818
|
| 72.
|
Perlman, H.,
Suzuki, E.,
Simonson, M.,
Smith, R. C.,
and Walsh, K.
(1998)
J. Biol. Chem.
273,
13713-13718
|
| 73.
|
Mano, T.,
Luo, Z.,
Malendowicz, S. L.,
Evans, T.,
and Walsh, K.
(1999)
Circ. Res.
84,
647-654
|
| 74.
|
Durocher, D.,
Charron, F.,
Warren, R.,
Schwartz, R. J.,
and Nemer, M.
(1997)
EMBO J.
16,
5687-5696
|
| 75.
|
Sepulveda, J. L.,
Belaguli, N.,
Nigam, V.,
Chen, C. Y.,
Nemer, M.,
and Schwartz, R. J.
(1998)
Mol. Cell. Biol.
18,
3405-3415
|
| 76.
|
Lee, Y.,
Shioi, T.,
Kasahara, H.,
Jobe, S. M.,
Wiese, R. J.,
Markham, B. E.,
and Izumo, S.
(1998)
Mol. Cell. Biol.
18,
3120-3129
|
| 77.
|
Molkentin, J. D.,
Lu, J. R.,
Antos, C. L.,
Markham, B.,
Richardson, J.,
Robbins, J.,
Grant, S. R.,
and Olson, E. N.
(1998)
Cell
93,
215-228
|
| 78.
|
Morin, S.,
Charron, F.,
Robitaille, L.,
and Nemer, M.
(2000)
EMBO J.
19,
2046-2055
|
| 79.
|
Kakita, T.,
Hasegawa, K.,
Morimoto, T.,
Kaburagi, S.,
Wada, H.,
and Sasayama, S.
(1999)
J. Biol. Chem.
274,
34096-34102
|
| 80.
|
Wada, H.,
Hasegawa, K.,
Morimoto, T.,
Kakita, T.,
Yanazume, T.,
and Sasayama, S.
(2000)
J. Biol. Chem.
275,
25330-25335
|
| 81.
|
Blobel, G. A.,
Nakajuma, T.,
Eckner, R.,
Montminy, M.,
and Orkin, S. H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2061-2066
|
| 82.
|
Lu, J. R.,
McKinsey, T. A.,
Xu, H.,
Wang, D. Z.,
Richardson, J. A.,
and Olson, E. N.
(1999)
Mol. Cell. Biol.
19,
4495-4502
|
| 83.
|
Svensson, E. C.,
Tufts, R. L.,
Polk, C. E.,
and Leiden, J. M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
956-961
|
| 84.
|
Tevosian, S. G.,
Deconinck, A. E.,
Cantor, A. B.,
Rieff, H. I.,
Fujiwara, Y.,
Corfas, G.,
and Orkin, S. H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
950-955
|
| 85.
|
Haenlin, M.,
Cubadda, Y.,
Blondeau, F.,
Heitzler, P.,
Lutz, Y.,
Simpson, P.,
and Ramain, P.
(1997)
Genes Dev.
11,
3096-3108
|
| 86.
|
Tevosian, S. G.,
Deconinck, A. E.,
Tanaka, M.,
Schinke, M.,
Litovsky, S. H.,
Izumo, S.,
Fujiwara, Y.,
and Orkin, S. H.
(2000)
Cell
101,
729-739
|
| 87.
|
Svensson, E. C.,
Huggins, G. S.,
Lin, H.,
Clendenin, C.,
Jiang, F.,
Tufts, R.,
Dardik, F. B.,
and Leiden, J. M.
(2000)
Nat. Genet.
25,
353-356
|
| 88.
|
Holmes, M.,
Turner, J.,
Fox, A.,
Chisholm, O.,
Crossley, M.,
and Chong, B.
(1999)
J. Biol. Chem.
274,
23491-23498
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. M.E.I. Hellebrekers, M. H.F.M. Lentjes, S. M. van den Bosch, V. Melotte, K. A.D. Wouters, K. L.J. Daenen, K. M. Smits, Y. Akiyama, Y. Yuasa, S. Sanduleanu, et al.
GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
Clin. Cancer Res.,
June 15, 2009;
15(12):
3990 - 3997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Peterkin, A. Gibson, and R. Patient
Common genetic control of haemangioblast and cardiac development in zebrafish
Development,
May 1, 2009;
136(9):
1465 - 1474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P M Lindholm, Y Soini, M Myllarniemi, S Knuutila, M Heikinheimo, V L Kinnula, and K Salmenkivi
Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma
J. Clin. Pathol.,
April 1, 2009;
62(4):
339 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ray, D. Dutta, M. A. K. Rumi, L. N. Kent, M. J. Soares, and S. Paul
Context-dependent Function of Regulatory Elements and a Switch in Chromatin Occupancy between GATA3 and GATA2 Regulate Gata2 Transcription during Trophoblast Differentiation
J. Biol. Chem.,
February 20, 2009;
284(8):
4978 - 4988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-I. Kim, S. J. Bultman, C. M. Kiefer, A. Dean, and E. H. Bresnick
BRG1 requirement for long-range interaction of a locus control region with a downstream promoter
PNAS,
February 17, 2009;
106(7):
2259 - 2264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Bouchard, H. Taniguchi, and R. S Viger
The effect of human GATA4 gene mutations on the activity of target gonadal promoters
J. Mol. Endocrinol.,
February 1, 2009;
42(2):
149 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Y. Hui and H. A. LaVoie
GATA4 Reduction Enhances 3',5'-Cyclic Adenosine 5'-Monophosphate-Stimulated Steroidogenic Acute Regulatory Protein Messenger Ribonucleic Acid and Progesterone Production in Luteinized Porcine Granulosa Cells
Endocrinology,
November 1, 2008;
149(11):
5557 - 5567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhou, T. A. Francis, H. Yang, W. Tseng, Q. Zhong, B. Frenkel, Edward. E. Morrisey, David. K. Ann, P. Minoo, E. D. Crandall, et al.
GATA-6 mediates transcriptional activation of aquaporin-5 through interactions with Sp1
Am J Physiol Cell Physiol,
November 1, 2008;
295(5):
C1141 - C1150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Afouda, J. Martin, F. Liu, A. Ciau-Uitz, R. Patient, and S. Hoppler
GATA transcription factors integrate Wnt signalling during heart development
Development,
October 1, 2008;
135(19):
3185 - 3190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rojas, S. W. Kong, P. Agarwal, B. Gilliss, W. T. Pu, and B. L. Black
GATA4 Is a Direct Transcriptional Activator of Cyclin D2 and Cdk4 and Is Required for Cardiomyocyte Proliferation in Anterior Heart Field-Derived Myocardium
Mol. Cell. Biol.,
September 1, 2008;
28(17):
5420 - 5431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Dinger, P. P. Amaral, T. R. Mercer, K. C. Pang, S. J. Bruce, B. B. Gardiner, M. E. Askarian-Amiri, K. Ru, G. Solda, C. Simons, et al.
Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation
Genome Res.,
September 1, 2008;
18(9):
1433 - 1445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ohguchi, T. Tanaka, A. Uchida, K. Magoori, H. Kudo, I. Kim, K. Daigo, I. Sakakibara, M. Okamura, H. Harigae, et al.
Hepatocyte Nuclear Factor 4{alpha} Contributes to Thyroid Hormone Homeostasis by Cooperatively Regulating the Type 1 Iodothyronine Deiodinase Gene with GATA4 and Kruppel-Like Transcription Factor 9
Mol. Cell. Biol.,
June 15, 2008;
28(12):
3917 - 3931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Rakha, J. S. Reis-Filho, and I. O. Ellis
Basal-Like Breast Cancer: A Critical Review
J. Clin. Oncol.,
May 20, 2008;
26(15):
2568 - 2581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takaya, T. Kawamura, T. Morimoto, K. Ono, T. Kita, A. Shimatsu, and K. Hasegawa
Identification of p300-targeted Acetylated Residues in GATA4 during Hypertrophic Responses in Cardiac Myocytes
J. Biol. Chem.,
April 11, 2008;
283(15):
9828 - 9835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo
Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease
Mol. Endocrinol.,
April 1, 2008;
22(4):
781 - 798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pokreisz, G. Marsboom, and S. Janssens
Pressure overload-induced right ventricular dysfunction and remodelling in experimental pulmonary hypertension: the right heart revisited
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H75 - H84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Feng, M. Ren, L. Chen, and C. S. Rubin
Properties, Regulation, and in Vivo Functions of a Novel Protein Kinase D: CAENORHABDITIS ELEGANS DKF-2 LINKS DIACYLGLYCEROL SECOND MESSENGER TO THE REGULATION OF STRESS RESPONSES AND LIFE SPAN
J. Biol. Chem.,
October 26, 2007;
282(43):
31273 - 31288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Y. Woon, P. J. Kaisaki, J. Braganca, M.-T. Bihoreau, J. C. Levy, M. Farrall, and D. Gauguier
Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes
PNAS,
September 4, 2007;
104(36):
14412 - 14417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kanematsu, A. Ramachandran, and R. M. Adam
GATA-6 mediates human bladder smooth muscle differentiation: involvement of a novel enhancer element in regulating {alpha}-smooth muscle actin gene expression
Am J Physiol Cell Physiol,
September 1, 2007;
293(3):
C1093 - C1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Philips, J. C. Kwok, and B. H. Chong
Analysis of the Signals and Mechanisms Mediating Nuclear Trafficking of GATA-4: LOSS OF DNA BINDING IS ASSOCIATED WITH LOCALIZATION IN INTRANUCLEAR SPECKLES
J. Biol. Chem.,
August 24, 2007;
282(34):
24915 - 24927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Jonckheere, A. Vincent, M. Perrais, M.-P. Ducourouble, A. K.-v. Male, J.-P. Aubert, P. Pigny, K. L. Carraway, J.-N. Freund, I. B. Renes, et al.
The Human Mucin MUC4 Is Transcriptionally Regulated by Caudal-related Homeobox, Hepatocyte Nuclear Factors, Forkhead Box A, and GATA Endodermal Transcription Factors in Epithelial Cancer Cells
J. Biol. Chem.,
August 3, 2007;
282(31):
22638 - 22650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kobayashi, K. Mao, H. Zheng, X. Wang, C. Patterson, T. D. O'Connell, and Q. Liang
Diminished GATA4 Protein Levels Contribute to Hyperglycemia-induced Cardiomyocyte Injury
J. Biol. Chem.,
July 27, 2007;
282(30):
21945 - 21952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bian, Z. B. Popovic, C. Benejam, M. Kiedrowski, L. L. Rodriguez, and M. S. Penn
Effect of Cell-Based Intercellular Delivery of Transcription Factor GATA4 on Ischemic Cardiomyopathy
Circ. Res.,
June 8, 2007;
100(11):
1626 - 1633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Belaguli, M. Zhang, M. Rigi, M. Aftab, and D. H. Berger
Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression
Am J Physiol Gastrointest Liver Physiol,
June 1, 2007;
292(6):
G1520 - G1533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Shadley, K. Divakaran, K. Munson, R. N. Hines, K. Douglas, and D. G. McCarver
Identification and Functional Analysis of a Novel Human CYP2E1 Far Upstream Enhancer
Mol. Pharmacol.,
June 1, 2007;
71(6):
1630 - 1639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Khandekar, W. Brandt, Y. Zhou, S. Dagenais, T. W. Glover, N. Suzuki, R. Shimizu, M. Yamamoto, K.-C. Lim, and J. D. Engel
A Gata2 intronic enhancer confers its pan-endothelia-specific regulation
Development,
May 1, 2007;
134(9):
1703 - 1712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fisch, S. Gray, S. Heymans, S. M. Haldar, B. Wang, O. Pfister, L. Cui, A. Kumar, Z. Lin, S. Sen-Banerjee, et al.
Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy
PNAS,
April 24, 2007;
104(17):
7074 - 7079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sharma, J. Masri, O. D. Jo, A. Bernath, J. Martin, A. Funk, and J. Gera
Protein Kinase C Regulates Internal Initiation of Translation of the GATA-4 mRNA following Vasopressin-induced Hypertrophy of Cardiac Myocytes
J. Biol. Chem.,
March 30, 2007;
282(13):
9505 - 9516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, N. Rath, S. Hannenhalli, Z. Wang, T. Cappola, S. Kimura, E. Atochina-Vasserman, M. M. Lu, M. F. Beers, and E. E. Morrisey
GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo
Development,
January 1, 2007;
134(1):
189 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Masuda, K. Hashimoto, T. Yokoi, T. Doi, T. Kodama, H. Kume, K. Ohno, and T. Matsuguchi
Essential Role of GATA Transcriptional Factors in the Activation of Mast Cells
J. Immunol.,
January 1, 2007;
178(1):
360 - 368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mazaud Guittot, A. Tetu, E. Legault, N. Pilon, D. W. Silversides, and R. S. Viger
The Proximal Gata4 Promoter Directs Reporter Gene Expression to Sertoli Cells During Mouse Gonadal Development
Biol Reprod,
January 1, 2007;
76(1):
85 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bosse, C. M. Piaseckyj, E. Burghard, J. J. Fialkovich, S. Rajagopal, W. T. Pu, and S. D. Krasinski
Gata4 Is Essential for the Maintenance of Jejunal-Ileal Identities in the Adult Mouse Small Intestine
Mol. Cell. Biol.,
December 1, 2006;
26(23):
9060 - 9070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Xu, L. Renaud, J. G. Muller, C. F. Baicu, D. D. Bonnema, H. Zhou, C. S. Kappler, S. W. Kubalak, M. R. Zile, S. J. Conway, et al.
Regulation of Ncx1 Expression: IDENTIFICATION OF REGULATORY ELEMENTS MEDIATING CARDIAC-SPECIFIC EXPRESSION AND UP-REGULATION
J. Biol. Chem.,
November 10, 2006;
281(45):
34430 - 34440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Looyenga and G. D. Hammer
Origin and Identity of Adrenocortical Tumors in Inhibin Knockout Mice: Implications for Cellular Plasticity in the Adrenal Cortex
Mol. Endocrinol.,
November 1, 2006;
20(11):
2848 - 2863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Herring, O. El-Mounayri, P. J. Gallagher, F. Yin, and J. Zhou
Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues
Am J Physiol Cell Physiol,
November 1, 2006;
291(5):
C817 - C827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bisping, S. Ikeda, S. W. Kong, O. Tarnavski, N. Bodyak, J. R. McMullen, S. Rajagopal, J. K. Son, Q. Ma, Z. Springer, et al.
Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure
PNAS,
September 26, 2006;
103(39):
14471 - 14476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shapira, B. J. Hamlin, J. Rong, K. Chen, M. Ronen, and M.-W. Tan
A conserved role for a GATA transcription factor in regulating epithelial innate immune responses
PNAS,
September 19, 2006;
103(38):
14086 - 14091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Xin, C. A. Davis, J. D. Molkentin, C.-L. Lien, S. A. Duncan, J. A. Richardson, and E. N. Olson
A threshold of GATA4 and GATA6 expression is required for cardiovascular development
PNAS,
July 25, 2006;
103(30):
11189 - 11194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Yin, A. M. Hoggatt, J. Zhou, and B. P. Herring
130-kDa smooth muscle myosin light chain kinase is transcribed from a CArG-dependent, internal promoter within the mouse mylk gene
Am J Physiol Cell Physiol,
June 1, 2006;
290(6):
C1599 - C1609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ding, C.-j. Liu, Y. Huang, R. P. Hickey, J. Yu, W. Kong, and P. Lengyel
p204 Is Required for the Differentiation of P19 Murine Embryonal Carcinoma Cells to Beating Cardiac Myocytes: ITS EXPRESSION IS ACTIVATED BY THE CARDIAC GATA4, NKX2.5, AND TBX5 PROTEINS
J. Biol. Chem.,
May 26, 2006;
281(21):
14882 - 14892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ding, C.-j. Liu, Y. Huang, J. Yu, W. Kong, and P. Lengyel
p204 Protein Overcomes the Inhibition of the Differentiation of P19 Murine Embryonal Carcinoma Cells to Beating Cardiac Myocytes by Id Proteins
J. Biol. Chem.,
May 26, 2006;
281(21):
14893 - 14906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Davis, M. Haberland, M. A. Arnold, L. B. Sutherland, O. G. McDonald, J. A. Richardson, G. Childs, S. Harris, G. K. Owens, and E. N. Olson
PRISM/PRDM6, a Transcriptional Repressor That Promotes the Proliferative Gene Program in Smooth Muscle Cells.
Mol. Cell. Biol.,
April 1, 2006;
26(7):
2626 - 2636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Perrino and H. A. Rockman
GATA4 and the Two Sides of Gene Expression Reprogramming
Circ. Res.,
March 31, 2006;
98(6):
715 - 716.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Oka, M. Maillet, A. J. Watt, R. J. Schwartz, B. J. Aronow, S. A. Duncan, and J. D. Molkentin
Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte Viability
Circ. Res.,
March 31, 2006;
98(6):
837 - 845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Perlman, T. Bouquin, B. van den Hazel, T.H. Jensen, H.T. Schambye, S. Knudsen, and J.S. Okkels
Transcriptome analysis of FSH and FSH variant stimulation in granulosa cells from IVM patients reveals novel regulated genes
Mol. Hum. Reprod.,
March 1, 2006;
12(3):
135 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Huggins, J. Y.Y. Wong, S. E. Hankinson, and I. De Vivo
GATA5 Activation of the Progesterone Receptor Gene Promoter in Breast Cancer Cells Is Influenced by the +331G/A Polymorphism
Cancer Res.,
February 1, 2006;
66(3):
1384 - 1390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. M. Ho, J. R. Wood, D. R. Stewart, K. Ewens, W. Ankener, J. Wickenheisser, V. Nelson-Degrave, Z. Zhang, R. S. Legro, A. Dunaif, et al.
Increased Transcription and Increased Messenger Ribonucleic Acid (mRNA) Stability Contribute to Increased GATA6 mRNA Abundance in Polycystic Ovary Syndrome Theca Cells
J. Clin. Endocrinol. Metab.,
December 1, 2005;
90(12):
6596 - 6602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Bouchard, H. Taniguchi, and R. S. Viger
Protein Kinase A-Dependent Synergism between GATA Factors and the Nuclear Receptor, Liver Receptor Homolog-1, Regulates Human Aromatase (CYP19) PII Promoter Activity in Breast Cancer Cells
Endocrinology,
November 1, 2005;
146(11):
4905 - 4916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T. Antoniv, S. Tanaka, B. Sudan, S. De Val, K. Liu, L. Wang, D. J. Wells, G. Bou-Gharios, and F. Ramirez
Identification of a Repressor in the First Intron of the Human {alpha}2(I) Collagen Gene (COL1A2)
J. Biol. Chem.,
October 21, 2005;
280(42):
35417 - 35423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rath, Z. Wang, M. M. Lu, and E. E. Morrisey
LMCD1/Dyxin Is a Novel Transcriptional Cofactor That Restricts GATA6 Function by Inhibiting DNA Binding
Mol. Cell. Biol.,
October 15, 2005;
25(20):
8864 - 8873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Radvanyi, D. Singh-Sandhu, S. Gallichan, C. Lovitt, A. Pedyczak, G. Mallo, K. Gish, K. Kwok, W. Hanna, J. Zubovits, et al.
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer
PNAS,
August 2, 2005;
102(31):
11005 - 11010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Hermann and L. L. Heckert
Silencing of Fshr Occurs through a Conserved, Hypersensitive Site in the First Intron
Mol. Endocrinol.,
August 1, 2005;
19(8):
2112 - 2131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Huang, A. Dardis, and W. L. Miller
Regulation of Cytochrome b5 Gene Transcription by Sp3, GATA-6, and Steroidogenic Factor 1 in Human Adrenal NCI-H295A Cells
Mol. Endocrinol.,
August 1, 2005;
19(8):
2020 - 2034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rojas, S. De Val, A. B. Heidt, S.-M. Xu, J. Bristow, and B. L. Black
Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element
Development,
August 1, 2005;
132(15):
3405 - 3417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhou, G. Hernandez, S.-w. Tu, J. Scholes, H. Chen, C.-P. Tseng, and J.-T. Hsieh
Synergistic Induction of DOC-2/DAB2 Gene Expression in Transitional Cell Carcinoma in the Presence of GATA6 and Histone Deacetylase Inhibitor
Cancer Res.,
July 15, 2005;
65(14):
6089 - 6096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Oskouian, J. Mendel, E. Shocron, M. A. Lee Jr., H. Fyrst, and J. D. Saba
Regulation of Sphingosine-1-phosphate Lyase Gene Expression by Members of the GATA Family of Transcription Factors
J. Biol. Chem.,
May 6, 2005;
280(18):
18403 - 18410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhao, A. J. Watt, J. Li, J. Luebke-Wheeler, E. E. Morrisey, and S. A. Duncan
GATA6 Is Essential for Embryonic Development of the Liver but Dispensable for Early Heart Formation
Mol. Cell. Biol.,
April 1, 2005;
25(7):
2622 - 2631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ritz-Laser, A. Mamin, T. Brun, I. Avril, V. M. Schwitzgebel, and J. Philippe
The Zinc Finger-Containing Transcription Factor Gata-4 Is Expressed in the Developing Endocrine Pancreas and Activates Glucagon Gene Expression
Mol. Endocrinol.,
March 1, 2005;
19(3):
759 - 770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ferreira, K. Ohneda, M. Yamamoto, and S. Philipsen
GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis
Mol. Cell. Biol.,
February 15, 2005;
25(4):
1215 - 1227.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Marusina, D.-K. Kim, L. D. Lieto, F. Borrego, and J. E. Coligan
GATA-3 Is an Important Transcription Factor for Regulating Human NKG2A Gene Expression
J. Immunol.,
February 15, 2005;
174(4):
2152 - 2159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Afouda, A. Ciau-Uitz, and R. Patient
GATA4, 5 and 6 mediate TGF{beta} maintenance of endodermal gene expression in Xenopus embryos
Development,
February 15, 2005;
132(4):
763 - 774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chandrasekar, S. Mummidi, W. C. Claycomb, R. Mestril, and M. Nemer
Interleukin-18 Is a Pro-hypertrophic Cytokine That Acts through a Phosphatidylinositol 3-Kinase-Phosphoinositide-dependent Kinase-1-Akt-GATA4 Signaling Pathway in Cardiomyocytes
J. Biol. Chem.,
February 11, 2005;
280(6):
4553 - 4567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Yin and B. P. Herring
GATA-6 Can Act as a Positive or Negative Regulator of Smooth Muscle-specific Gene Expression
J. Biol. Chem.,
February 11, 2005;
280(6):
4745 - 4752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Sarkozy, E Conti, C Neri, R D'Agostino, M C Digilio, G Esposito, A Toscano, B Marino, A Pizzuti, and B Dallapiccola
Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors
J. Med. Genet.,
February 1, 2005;
42(2):
e16 - e16.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Lepore, T. P. Cappola, P. A. Mericko, E. E. Morrisey, and M. S. Parmacek
GATA-6 Regulates Genes Promoting Synthetic Functions in Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2005;
25(2):
309 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Martowicz, J. A. Grass, M. E. Boyer, H. Guend, and E. H. Bresnick
Dynamic GATA Factor Interplay at a Multicomponent Regulatory Region of the GATA-2 Locus
J. Biol. Chem.,
January 21, 2005;
280(3):
1724 - 1732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Saner, T. Suzuki, H. Sasano, J. Pizzey, C. Ho, J. F. Strauss III, B. R. Carr, and W. E. Rainey
Steroid Sulfotransferase 2A1 Gene Transcription Is Regulated by Steroidogenic Factor 1 and GATA-6 in the Human Adrenal
Mol. Endocrinol.,
January 1, 2005;
19(1):
184 - 197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Liang, C. Hassett, and C. J. Omiecinski
Alternative Promoters Determine Tissue-Specific Expression Profiles of the Human Microsomal Epoxide Hydrolase Gene (EPHX1)
Mol. Pharmacol.,
January 1, 2005;
67(1):
220 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Masuda, Y. Yoshikai, H. Kume, and T. Matsuguchi
The Interaction between GATA Proteins and Activator Protein-1 Promotes the Transcription of IL-13 in Mast Cells
J. Immunol.,
November 1, 2004;
173(9):
5564 - 5573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Xu, M. Wani, Y.-S. Dai, J. Wang, M. Yan, A. Ayub, and M. Ashraf
Differentiation of Bone Marrow Stromal Cells Into the Cardiac Phenotype Requires Intercellular Communication With Myocytes
Circulation,
October 26, 2004;
110(17):
2658 - 2665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. van Wering, T. Bosse, A. Musters, E. de Jong, N. de Jong, C. E. Hogen Esch, F. Boudreau, G. P. Swain, L. N. Dowling, R. K. Montgomery, et al.
Complex regulation of the lactase-phlorizin hydrolase promoter by GATA-4
Am J Physiol Gastrointest Liver Physiol,
October 1, 2004;
287(4):
G899 - G909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Lee, S. Evans, T. Y. Ruan, and A. B. Lassar
SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer
Development,
October 1, 2004;
131(19):
4709 - 4723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Watt, M. A. Battle, J. Li, and S. A. Duncan
GATA4 is essential for formation of the proepicardium and regulates cardiogenesis
PNAS,
August 24, 2004;
101(34):
12573 - 12578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Vanpoucke, S. Goossens, B. De Craene, B. Gilbert, F. van Roy, and G. Berx
GATA-4 and MEF2C transcription factors control the tissue-specific expression of the {alpha}T-catenin gene CTNNA3
Nucleic Acids Res.,
August 9, 2004;
32(14):
4155 - 4165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pikkarainen, H. Tokola, R. Kerkela, and H. Ruskoaho
GATA transcription factors in the developing and adult heart
Cardiovasc Res,
August 1, 2004;
63(2):
196 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Barrett, K. S. Gustafson, J. Wang, S. Z. Wang, and G. D. Ginder
A GATA Factor Mediates Cell Type-Restricted Induction of HLA-E Gene Transcription by Gamma Interferon
Mol. Cell. Biol.,
July 15, 2004;
24(14):
6194 - 6204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Murakami, H. Shen, S. Ishida, and C. Dickson
SOX7 and GATA-4 Are Competitive Activators of Fgf-3 Transcription
J. Biol. Chem.,
July 2, 2004;
279(27):
28564 - 28573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Viger, H. Taniguchi, N. M. Robert, and J. J. Tremblay
The 25th Volume: Role of the GATA Family of Transcription Factors in Andrology
J Androl,
July 1, 2004;
25(4):
441 - 452.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Tenhunen, B. Sarman, R. Kerkela, I. Szokodi, L. Papp, M. Toth, and H. Ruskoaho
Mitogen-activated Protein Kinases p38 and ERK 1/2 Mediate the Wall Stress-induced Activation of GATA-4 Binding in Adult Heart
J. Biol. Chem.,
June 4, 2004;
279(23):
24852 - 24860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Nesbit, M. R. Bowl, B. Harding, A. Ali, A. Ayala, C. Crowe, A. Dobbie, G. Hampson, I. Holdaway, M. A. Levine, et al.
Characterization of GATA3 Mutations in the Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) Syndrome
J. Biol. Chem.,
May 21, 2004;
279(21):
22624 - 22634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Fluck and W. L. Miller
GATA-4 and GATA-6 Modulate Tissue-Specific Transcription of the Human Gene for P450c17 by Direct Interaction with Sp1
Mol. Endocrinol.,
May 1, 2004;
18(5):
1144 - 1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takeda, K. Obayashi, A. Kobayashi, and M. Maeda
A Unique Role of an Amino Terminal 16-Residue Region of Long-Type GATA-6
J. Biochem.,
May 1, 2004;
135(5):
639 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. O. Brown III, X. Chi, E. Garcia-Gras, M. Shirai, X.-H. Feng, and R. J. Schwartz
The Cardiac Determination Factor, Nkx2-5, Is Activated by Mutual Cofactors GATA-4 and Smad1/4 via a Novel Upstream Enhancer
J. Biol. Chem.,
March 12, 2004;
279(11):
10659 - 10669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Purcell, D. Darwis, O. F. Bueno, J. M. Muller, R. Schule, and J. D. Molkentin
Extracellular Signal-Regulated Kinase 2 Interacts with and Is Negatively Regulated by the LIM-Only Protein FHL2 in Cardiomyocytes
Mol. Cell. Biol.,
February 1, 2004;
24(3):
1081 - 1095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. V. Latinkic, B. Cooper, S. Smith, S. Kotecha, N. Towers, D. Sparrow, and T. J. Mohun
Transcriptional regulation of the cardiac-specific MLC2 gene during Xenopus embryonic development
Development,
February 1, 2004;
131(3):
669 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pal, A. B. Cantor, K. D. Johnson, T. B. Moran, M. E. Boyer, S. H. Orkin, and E. H. Bresnick
Coregulator-dependent facilitation of chromatin occupancy by GATA-1
PNAS,
January 27, 2004;
101(4):
980 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Letting, Y.-Y. Chen, C. Rakowski, S. Reedy, and G. A. Blobel
Context-dependent regulation of GATA-1 by friend of GATA-1
PNAS,
January 13, 2004;
101(2):
476 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Pang, M. Bartlam, Q. Zeng, H. Miyatake, T. Hisano, K. Miki, L.-L. Wong, G. F. Gao, and Z. Rao
Crystal Structure of Human Pirin: AN IRON-BINDING NUCLEAR PROTEIN AND TRANSCRIPTION COFACTOR
J. Biol. Chem.,
January 9, 2004;
279(2):
1491 - 1498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lei and L. L. Heckert
Gata4 Regulates Testis Expression of Dmrt1
Mol. Cell. Biol.,
January 1, 2004;
24(1):
377 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mesquita, N. Jonckheere, R. Almeida, M.-P. Ducourouble, J. Serpa, E. Silva, P. Pigny, F. S. Silva, C. Reis, D. Silberg, et al.
Human MUC2 Mucin Gene Is Transcriptionally Regulated by Cdx Homeodomain Proteins in Gastrointestinal Carcinoma Cell Lines
J. Biol. Chem.,
December 19, 2003;
278(51):
51549 - 51556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Akiyama, N. Watkins, H. Suzuki, K.-W. Jair, M. van Engeland, M. Esteller, H. Sakai, C.-Y. Ren, Y. Yuasa, J. G. Herman, et al.
GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer
Mol. Cell. Biol.,
December 1, 2003;
23(23):
8429 - 8439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. LaVoie
The Role of GATA in Mammalian Reproduction
Experimental Biology and Medicine,
December 1, 2003;
228(11):
1282 - 1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Katz, A. Williams, J. Yang, Y. Fujiwara, A. P. Tsang, J. A. Epstein, and S. H. Orkin
Endothelial lineage-mediated loss of the GATA cofactor Friend of GATA 1 impairs cardiac development
PNAS,
November 25, 2003;
100(24):
14030 - 14035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dobrev
Transcription factors for ion channels: active or passive players in cardiac remodeling?
Cardiovasc Res,
November 1, 2003;
60(2):
226 - 227.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jimenez, K. Saner, B. Mayhew, and W. E. Rainey
GATA-6 Is Expressed in the Human Adrenal and Regulates Transcription of Genes Required for Adrenal Androgen Biosynthesis
Endocrinology,
October 1, 2003;
144(10):
4285 - 4288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Benchabane and J. L. Wrana
GATA- and Smad1-Dependent Enhancers in the Smad7 Gene Differentially Interpret Bone Morphogenetic Protein Concentrations
Mol. Cell. Biol.,
September 15, 2003;
23(18):
6646 - 6661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lindeboom, N. Gillemans, A. Karis, M. Jaegle, D. Meijer, F. Grosveld, and S. Philipsen
A tissue-specific knockout reveals that Gata1 is not essential for Sertoli cell function in the mouse
Nucleic Acids Res.,
September 15, 2003;
31(18):
5405 - 5412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Corti, R. W. E. Clarkson, L. Crepaldi, C. F. Sala, J. H. Xuereb, and F. Ferraguti
Gene Structure of the Human Metabotropic Glutamate Receptor 5 and Functional Analysis of Its Multiple Promoters in Neuroblastoma and Astroglioma Cells
J. Biol. Chem.,
August 29, 2003;
278(35):
33105 - 33119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Capo-chichi, I. H. Roland, L. Vanderveer, R. Bao, T. Yamagata, H. Hirai, C. Cohen, T. C. Hamilton, A. K. Godwin, and X.-X. Xu
Anomalous Expression of Epithelial Differentiation-determining GATA Factors in Ovarian Tumorigenesis
Cancer Res.,
August 15, 2003;
63(16):
4967 - 4977.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|